Interferon-based chemoradiation followed by gemcitabine for resected pancreatic adenocarcinoma: long-term follow-up. [electronic resource]
Producer: 20180305Description: 449-457 p. digitalISSN:- 1477-2574
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Carcinoma, Pancreatic Ductal -- mortality
- Chemoradiotherapy, Adjuvant -- adverse effects
- Chi-Square Distribution
- Cisplatin -- administration & dosage
- Deoxycytidine -- administration & dosage
- Disease Progression
- Disease-Free Survival
- Dose Fractionation, Radiation
- Drug Administration Schedule
- Female
- Fluorouracil -- administration & dosage
- Follow-Up Studies
- Humans
- Interferon-alpha -- administration & dosage
- Kaplan-Meier Estimate
- Logistic Models
- Male
- Middle Aged
- Missouri
- Multivariate Analysis
- Neoplasm Recurrence, Local
- Pancreatic Neoplasms -- mortality
- Pancreaticoduodenectomy -- adverse effects
- Risk Factors
- Time Factors
- Treatment Outcome
- Gemcitabine
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article
There are no comments on this title.
Log in to your account to post a comment.